ARWR : Arrowhead Pharmaceuticals stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-01-10 |
|---|---|---|---|---|
| 2025 | $48.95 | $21.29 | $60.82 | 164.75% |
| 2026 | $38.27 | $19.0 | $55.61 | 106.97% |
| 2027 | $9.67 | $5.29 | $16.97 | -47.69% |
| 2028 | $9.09 | $5.63 | $11.2 | -50.85% |
| 2029 | $5.94 | $2.47 | $10.02 | -67.88% |
| 2030 | $6.16 | $2.23 | $15.18 | -66.69% |
| 2031 | $32.15 | $15.91 | $53.24 | 73.89% |
| 2032 | $41.32 | $23.62 | $53.74 | 123.49% |
| 2033 | $9.44 | $3.35 | $20.19 | -48.94% |
| 2034 | $8.46 | $3.39 | $14.48 | -54.22% |
| 2035 | $14.95 | $14.95 | $14.95 | -19.12% |
The 16 Wall Street analysts offering Arrowhead Pharmaceuticals stock forecast in the last 6 months have average price target of
$55.88 with a high forecast of $80.0 and a low forecast of $24.0.
The average Arrowhead Pharmaceuticals stock forecast represents a 202.22%
increase from the last price of $18.4899997711182.
For Arrowhead Pharmaceuticals stock forecast for 2025, 11 predictions are offered for each month of 2025 with average Arrowhead Pharmaceuticals stock
forecast of $48.95, a high forecast of $60.82, and a low forecast of $21.29.
The average Arrowhead Pharmaceuticals stock forecast 2025 represents a 164.75%
increase from the last price of $18.4899997711182.
For Arrowhead Pharmaceuticals stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Arrowhead Pharmaceuticals stock
forecast of $38.27, a high forecast of $55.61, and a low forecast of $19.0.
The average Arrowhead Pharmaceuticals stock forecast 2026 represents a 106.97%
increase from the last price of $18.4899997711182.
For Arrowhead Pharmaceuticals stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Arrowhead Pharmaceuticals stock
forecast of $9.09, a high forecast of $11.2, and a low forecast of $5.63.
The average Arrowhead Pharmaceuticals stock forecast 2028 represents a -50.85%
decrease from the last price of $18.4899997711182.
For Arrowhead Pharmaceuticals stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Arrowhead Pharmaceuticals stock
forecast of $6.16, a high forecast of $15.18, and a low forecast of $2.23.
The average Arrowhead Pharmaceuticals stock forecast 2030 represents a -66.69%
decrease from the last price of $18.4899997711182.
For Arrowhead Pharmaceuticals stock forecast 2031, 12 predictions are offered for each month of 2031 with average Arrowhead Pharmaceuticals stock
forecast of $32.15, a high forecast of $53.24, and a low forecast of $15.91.
The average Arrowhead Pharmaceuticals stock forecast 2031 represents a 73.89%
increase from the last price of $18.4899997711182.
For Arrowhead Pharmaceuticals stock forecast for 2035 (10 year), 1 predictions are offered for each month of 2035 with average Arrowhead Pharmaceuticals stock
forecast of $14.95, a high forecast of $14.95, and a low forecast of $14.95.
The average Arrowhead Pharmaceuticals stock forecast 2035 represents a -19.12%
decrease from the last price of $18.4899997711182.
Please, see more forecasts below.
ARWR : Arrowhead Pharmaceuticals stock forecast by Wall Street Analysts
The average Arrowhead Pharmaceuticals stock forecast from last 6 month is $55.88, and this show a -0.11% decrease in average from the prior price target of the each prediction. Also, this average forecast of $55.88 represents a -5.51% decrease from the past average forecast of $59.14, 6 months ago from 14 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-12-20 | HC Wainwright & Co. | $80.0000 | $80.0000 | Buy |
| 2024-12-12 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-12-03 | HC Wainwright & Co. | $60.00 | $80.0000 | Buy |
| 2024-11-29 | Bernstein | $27.0000 | $24.0000 | Market Perform |
| 2024-11-27 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-11-27 | Citigroup | $27.0000 | $26.0000 | Neutral |
| 2024-11-27 | Piper Sandler | $62.00 | $45 | Overweight |
| 2024-11-20 | HC Wainwright & Co. | $60.00 | $60.00 | Buy |
| 2024-10-11 | HC Wainwright & Co. | $60.00 | $60.0000 | Buy |
| 2024-10-08 | Piper Sandler | $62.0000 | $62 | Overweight |
| 2024-09-26 | RBC Capital | $42.0000 | $42 | Outperform |
| 2024-09-09 | Cantor Fitzgerald | Overweight | ||
| 2024-09-05 | HC Wainwright & Co. | $60.00 | $60.00 | Buy |
| 2024-09-03 | HC Wainwright & Co. | $60.00 | $60.00 | Buy |
| 2024-08-12 | B. Riley Securities | $55.00 | $55 | Buy |
| 2024-07-23 | HC Wainwright & Co. | $60.00 | $60.00 | Buy |
| 2024-07-17 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-07-05 | HC Wainwright & Co. | $90.00 | $60 | Buy |
| 2024-06-26 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-06-20 | Cantor Fitzgerald | Overweight | ||
| 2024-06-11 | HC Wainwright & Co. | $90.00 | $90.00 | Buy |
| 2024-06-05 | Goldman Sachs | $31.0000 | Neutral | |
| 2024-06-03 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-06-03 | HC Wainwright & Co. | $90.00 | $90.0000 | Buy |
| 2024-05-13 | HC Wainwright & Co. | $90.0000 | Buy | |
| 2024-05-13 | Morgan Stanley | $36.00 | $27 | Equal-Weight |
| 2024-05-10 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-02-08 | HC Wainwright & Co. | $90.0000 | Buy | |
| 2024-02-07 | Morgan Stanley | $34.0000 | $36.0000 | Equal-Weight |
| 2024-02-07 | RBC Capital | $50.0000 | Outperform | |
| 2024-02-07 | Citigroup | $33.00 | $34 | Neutral |
| 2024-01-16 | RBC Capital | $50.0000 | Outperform |
Arrowhead Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-01-13 | $18.60 | 0.58% |
| 2025-01-14 | $18.71 | 0.58% |
| 2025-01-15 | $18.72 | 0.05% |
| 2025-01-16 | $18.75 | 0.16% |
| 2025-01-17 | $18.73 | -0.10% |
ARWR : Long term Arrowhead Pharmaceuticals stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Feb. is $21.29 , for 2026 Jan. is $55.61 , for 2029 Jan. is $10.02 , for 2030 Jan. is $2.27 , for 2034 Jan. is $3.39 , and for 2035 Jan. is $14.95.
ARWR : Arrowhead Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Feb. | $21.29 | 15.14% |
| 2025 Mar. | $27.25 | 28.00% |
| 2025 Apr. | $35.88 | 31.67% |
| 2025 May. | $46.24 | 28.87% |
| 2025 Jun. | $54.44 | 17.73% |
| 2025 Jul. | $57.17 | 5.02% |
| 2025 Aug. | $58.15 | 1.71% |
| 2025 Sep. | $58.94 | 1.36% |
| 2025 Oct. | $59.95 | 1.73% |
| 2025 Nov. | $60.82 | 1.44% |
| 2025 Dec. | $58.35 | -4.06% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $55.61 | -4.69% |
| 2026 Feb. | $53.97 | -2.96% |
| 2026 Mar. | $51.54 | -4.51% |
| 2026 Apr. | $48.51 | -5.87% |
| 2026 May. | $44.98 | -7.28% |
| 2026 Jun. | $41.13 | -8.54% |
| 2026 Jul. | $37.07 | -9.87% |
| 2026 Aug. | $32.75 | -11.66% |
| 2026 Sep. | $28.43 | -13.20% |
| 2026 Oct. | $24.68 | -13.20% |
| 2026 Nov. | $21.55 | -12.67% |
| 2026 Dec. | $19.00 | -11.82% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $16.97 | -10.71% |
| 2027 Feb. | $15.28 | -9.96% |
| 2027 Mar. | $13.78 | -9.82% |
| 2027 Apr. | $12.32 | -10.58% |
| 2027 May. | $10.86 | -11.86% |
| 2027 Jun. | $9.42 | -13.29% |
| 2027 Jul. | $8.11 | -13.89% |
| 2027 Aug. | $7.01 | -13.51% |
| 2027 Sep. | $6.16 | -12.19% |
| 2027 Oct. | $5.57 | -9.58% |
| 2027 Nov. | $5.29 | -5.01% |
| 2027 Dec. | $5.31 | 0.45% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $5.63 | 6.03% |
| 2028 Feb. | $6.21 | 10.27% |
| 2028 Mar. | $6.94 | 11.66% |
| 2028 Apr. | $7.70 | 11.03% |
| 2028 May. | $8.51 | 10.46% |
| 2028 Jun. | $9.35 | 9.88% |
| 2028 Jul. | $10.14 | 8.46% |
| 2028 Aug. | $10.74 | 5.96% |
| 2028 Sep. | $11.11 | 3.46% |
| 2028 Oct. | $11.20 | 0.74% |
| 2028 Nov. | $10.97 | -2.04% |
| 2028 Dec. | $10.56 | -3.70% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $10.02 | -5.16% |
| 2029 Feb. | $9.35 | -6.62% |
| 2029 Mar. | $8.59 | -8.14% |
| 2029 Apr. | $7.80 | -9.25% |
| 2029 May. | $7.05 | -9.54% |
| 2029 Jun. | $6.24 | -11.51% |
| 2029 Jul. | $5.36 | -14.18% |
| 2029 Aug. | $4.53 | -15.37% |
| 2029 Sep. | $3.82 | -15.63% |
| 2029 Oct. | $3.25 | -15.13% |
| 2029 Nov. | $2.79 | -13.92% |
| 2029 Dec. | $2.47 | -11.68% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $2.27 | -7.82% |
| 2030 Feb. | $2.23 | -2.02% |
| 2030 Mar. | $2.34 | 5.14% |
| 2030 Apr. | $2.63 | 12.15% |
| 2030 May. | $3.10 | 17.78% |
| 2030 Jun. | $3.77 | 21.82% |
| 2030 Jul. | $4.71 | 24.94% |
| 2030 Aug. | $6.03 | 28.07% |
| 2030 Sep. | $7.92 | 31.25% |
| 2030 Oct. | $10.48 | 32.25% |
| 2030 Nov. | $13.25 | 26.52% |
| 2030 Dec. | $15.18 | 14.50% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $15.91 | 4.86% |
| 2031 Feb. | $16.53 | 3.86% |
| 2031 Mar. | $17.84 | 7.91% |
| 2031 Apr. | $20.13 | 12.85% |
| 2031 May. | $23.32 | 15.85% |
| 2031 Jun. | $27.30 | 17.08% |
| 2031 Jul. | $32.15 | 17.77% |
| 2031 Aug. | $37.67 | 17.17% |
| 2031 Sep. | $43.01 | 14.16% |
| 2031 Oct. | $47.58 | 10.64% |
| 2031 Nov. | $51.16 | 7.53% |
| 2031 Dec. | $53.24 | 4.05% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $53.74 | 0.95% |
| 2032 Feb. | $53.03 | -1.32% |
| 2032 Mar. | $51.57 | -2.76% |
| 2032 Apr. | $49.62 | -3.79% |
| 2032 May. | $47.22 | -4.82% |
| 2032 Jun. | $44.49 | -5.79% |
| 2032 Jul. | $41.48 | -6.77% |
| 2032 Aug. | $38.18 | -7.95% |
| 2032 Sep. | $34.66 | -9.22% |
| 2032 Oct. | $31.00 | -10.56% |
| 2032 Nov. | $27.27 | -12.03% |
| 2032 Dec. | $23.62 | -13.40% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $20.19 | -14.52% |
| 2033 Feb. | $17.14 | -15.10% |
| 2033 Mar. | $14.56 | -15.05% |
| 2033 Apr. | $12.40 | -14.87% |
| 2033 May. | $10.54 | -14.96% |
| 2033 Jun. | $8.90 | -15.53% |
| 2033 Jul. | $7.44 | -16.47% |
| 2033 Aug. | $6.11 | -17.82% |
| 2033 Sep. | $4.97 | -18.72% |
| 2033 Oct. | $4.11 | -17.23% |
| 2033 Nov. | $3.57 | -13.11% |
| 2033 Dec. | $3.35 | -6.13% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $3.39 | 1.01% |
| 2034 Feb. | $3.63 | 7.03% |
| 2034 Mar. | $4.12 | 13.51% |
| 2034 Apr. | $4.93 | 19.88% |
| 2034 May. | $6.02 | 22.03% |
| 2034 Jun. | $7.26 | 20.56% |
| 2034 Jul. | $8.64 | 18.99% |
| 2034 Aug. | $10.17 | 17.80% |
| 2034 Sep. | $11.76 | 15.62% |
| 2034 Oct. | $13.14 | 11.73% |
| 2034 Nov. | $14.04 | 6.80% |
| 2034 Dec. | $14.48 | 3.18% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $14.95 | 3.26% |
Frequently Asked Questions about Arrowhead Pharmaceuticals stock forecast
Is Arrowhead Pharmaceuticals a good long term stock?
From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock can be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2025 Feb. is $21.2896299257149 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock can be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2026 Jan. is $55.6145229786144 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2029 Jan. is $10.0161569710268 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2030 Jan. is $2.27477032606767 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2034 Jan. is $3.38732339261786 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2035 Jan. is $14.9549819784164
Is Arrowhead Pharmaceuticals stock overvalued?
Arrowhead Pharmaceuticals (ARWR) stock is expected to go UP . Therefore, AIPickup would say that Arrowhead Pharmaceuticals (ARWR) stock is NOT overvalued.
Will Arrowhead Pharmaceuticals stock price go up?
Yes. The Arrowhead Pharmaceuticals stock price forecast for 2026 Jan. is $55.6145229786144
Is Arrowhead Pharmaceuticals stock a good buy now?
Since closing price on 2025-01-10 is $18.4899997711182 and forecast for 2026 Jan. is $55.61, Arrowhead Pharmaceuticals stock is a good 1 year investment.
14 Days Historical Data for Arrowhead Pharmaceuticals stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| ARWR stock price for 2024-12-19 | $19.50 | $20.32 | $19.21 | $20.35 |
| ARWR stock price for 2024-12-20 | $19.45 | $19.38 | $19.18 | $20.21 |
| ARWR stock price for 2024-12-23 | $19.75 | $19.50 | $19.35 | $19.95 |
| ARWR stock price for 2024-12-24 | $19.63 | $19.78 | $19.10 | $19.93 |
| ARWR stock price for 2024-12-26 | $19.53 | $19.31 | $19.10 | $19.80 |
| ARWR stock price for 2024-12-27 | $18.96 | $19.45 | $18.87 | $20.11 |
| ARWR stock price for 2024-12-30 | $18.61 | $18.86 | $18.40 | $19.03 |
| ARWR stock price for 2024-12-31 | $18.80 | $18.78 | $18.25 | $19.23 |
| ARWR stock price for 2025-01-02 | $19.65 | $18.94 | $18.66 | $19.94 |
| ARWR stock price for 2025-01-03 | $19.79 | $19.67 | $19.56 | $20.54 |
| ARWR stock price for 2025-01-06 | $19.50 | $19.79 | $19.16 | $20.30 |
| ARWR stock price for 2025-01-07 | $19.67 | $19.48 | $19.42 | $20.48 |
| ARWR stock price for 2025-01-08 | $19.75 | $19.32 | $19.32 | $20.78 |
| ARWR stock price for 2025-01-10 | $18.49 | $19.18 | $18.10 | $19.41 |